RSS Atom • ISSN 1472-4683 • Subscribe • About
2000
- Fifth International Congress on Drug Therapy in HIV Infection, 22 – 26 October 2000, Glasgow, UK Conference reports - Conference index - HIV 5 Glasgow 2000 - 17 December 2000
- Treatment strategies in 2000: planning first-line (and therefore, second-line) therapy Conference reports - HIV 5 Glasgow 2000 - 17 December 2000
- MDR resistance transmission increases in the UK Conference reports - Resistance - HIV 5 Glasgow 2000 - 17 December 2000
- Interferon-gamma treatment in azole-resistant oropharyngeal candidiasis Conference reports - Opportunistic infections and complications - HIV 5 Glasgow 2000 - 17 December 2000
- Further reports of avascular necrosis (AVN) and changes in bone mineral density (BMD) Conference reports - Side effects - HIV 5 Glasgow 2000 - 17 December 2000
- Antiretroviral therapy in children, women and intravenous drug users Conference reports - Paediatric care - Women's health - HIV 5 Glasgow 2000 - 17 December 2000
- Treatment of HIV+ subjects co-infected with hepatitis B or C: safety and efficacy comparison of ABT 378/r versus nelfinavir from a phase III blinded randomised clinical trial Conference reports - Hepatitis coinfection - HIV 5 Glasgow 2000 - 17 December 2000
- Interferon-alpha and ribavarin therapy for hepatitis C in HIV coinfected patients Conference reports - Hepatitis coinfection - HIV 5 Glasgow 2000 - 17 December 2000
- Lack of significant viral load alterations of hepatitis B virus (HBV) and hepatitis C virus (HCV) during treatment with interleukin-2 and HAART Conference reports - Hepatitis coinfection - HIV 5 Glasgow 2000 - 17 December 2000
- Child protection issues around starting efavirenz in a mother on maintenance methadone Conference reports - HIV 5 Glasgow 2000 - 17 December 2000
- Structured treatment interruptions Conference reports - Treatment strategies - HIV 5 Glasgow 2000 - 17 December 2000
- Opportunistic infections in the HAART era Conference reports - Opportunistic infections and complications - HIV 5 Glasgow 2000 - 17 December 2000
- Antiretrovirals do not independently affect T-cell count in HIV-negative subjects Basic science and immunology - 17 December 2000
- Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells Basic science and immunology - 17 December 2000
- HLA-DR integrates with HIV-1 at chronic disease stage, may raise infectivity Basic science and immunology - 17 December 2000
- Women initiate highly active antiretroviral therapy later than men Women's health - 17 December 2000
- Association of vitamin A deficiency With cervical squamous intraepithelial lesions in HIV-positive women Women's health - 17 December 2000
- HIV seroprevalence by anonymous testing in patients with mycobacterium tuberculosis and in tuberculosis contacts Other news - 17 December 2000
- Immune Response Corporation tried to block report on failure of Remune Vaccines and microbicides - 17 December 2000
- 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy, Toronto, Canada, 13-15 September 2000 Conference reports - Conference index - Lipodystrophy Workshop (IWADRLH) 2 Toronto 2000 - 17 October 2000
- Lactic acidosis Conference reports - Side effects - Lipodystrophy Workshop (IWADRLH) 2 Toronto 2000 - 17 October 2000
- Lipodystrophy and metabolic changes in children Conference reports - Paediatric care - Lipodystrophy Workshop (IWADRLH) 2 Toronto 2000 - 17 October 2000
- 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17-20 September 2000 Conference reports - Conference index - ICAAC 40th Toronto 2000 - 17 October 2000
- Mitochondrial toxicity reports Conference reports - Side effects - ICAAC 40th Toronto 2000 - 17 October 2000
- Treatment interruption and salvage therapy Conference reports - Resistance - ICAAC 40th Toronto 2000 - 17 October 2000
- Are gender-related differences in viral load present in infants and children? Conference reports - Paediatric care - ICAAC 40th Toronto 2000 - 17 October 2000
- Immune reconstitution in children treated with HAART is independent of age Conference reports - Paediatric care - ICAAC 40th Toronto 2000 - 17 October 2000
- Pharmacokinetics in children and infants Conference reports - Paediatric care - ICAAC 40th Toronto 2000 - 17 October 2000
- Opportunistic illness and viral hepatitis co-infection Conference reports - Hepatitis coinfection - Opportunistic infections and complications - ICAAC 40th Toronto 2000 - 17 October 2000
- Study shows immune system can control HIV: early antiviral treatment primes the immune system to suppress viral levels without drugs Basic science and immunology - Treatment strategies - 17 October 2000
- Enhancement of HIV type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption Basic science and immunology - 17 October 2000
- Human IL-12 may augment HIV-specific immunity in HIV-positive patients Treatment strategies - 17 October 2000
- United Kingdom authorities clear AIDS vaccine for human testing Vaccines and microbicides - 17 October 2000
- Highly active antiretroviral therapy should continue even if immune restoration syndrome develops Opportunistic infections and complications - 17 October 2000
- Abacavir hypersensitivity cases following an interruption of therapy Treatment alerts - 16 September 2000
- Structured treatment interruptions and treatment intensification Treatment strategies - CROI 7 (Retrovirus) 2000 - 16 September 2000
- Duration of incubation affects subsequent rate of HIV disease progression Basic science and immunology - 16 September 2000
- Population of HIV-targeted CD8 cells fluctuates with viral load during chronic infection Basic science and immunology - 16 September 2000
- Murabutide inhibits HIV replication in macrophages and dendritic cells Vaccines and microbicides - 16 September 2000
- Adverse effects of perinatal zidovudine exposure on HIV-infected infants Paediatric care - 16 September 2000
- Early cognitive and motor developmental delays in HIV-infected infants Paediatric care - 16 September 2000
- Topical cidofovir clears severe molluscum contagiosum in children with AIDS Opportunistic infections and complications - Paediatric care - 16 September 2000
- Prevalence of psoriatic arthritis increasing among HIV-positive black Zambians Opportunistic infections and complications - 16 September 2000
- Severe Hypersensitivity Reactions following reintroduction with Ziagen (abacavir sulphate) Treatment alerts - 16 August 2000
- XIII International AIDS Conference, Durban, South Africa, 9-14th July 2000 Conference reports - Conference index - World AIDS 13 Durban 2000 - 16 August 2000
- Mother-to-child transmission, maternal health and women's access to care Conference reports - PMTCT and maternal health - World AIDS 13 Durban 2000 - 16 August 2000
- The M in MTCT: questions about HIV-positive mothers Conference reports - PMTCT and maternal health - World AIDS 13 Durban 2000 - 16 August 2000
- First report of ABT-378/r use in children Conference reports - Paediatric care - World AIDS 13 Durban 2000 - 16 August 2000
- Nelfinavir doses should be increased in infants less than 3 months Conference reports - Paediatric care - World AIDS 13 Durban 2000 - 16 August 2000
- Commentary on STI talk, early entry inhibitor research, increase in viral replication seen in isolates in presence of NNRTIs Conference reports - World AIDS 13 Durban 2000 - 16 August 2000
- New developments in affordable antiretroviral therapy: intermittent treatment Conference reports - Treatment strategies - World AIDS 13 Durban 2000 - 16 August 2000
- Cannabinoids effect on HIV-1 viral load and appetite Conference reports - World AIDS 13 Durban 2000 - 16 August 2000
- IL-2 without HAART may delay need for antiretroviral treatment Conference reports - World AIDS 13 Durban 2000 - 16 August 2000
- Mitochondrial DNA (mtDNA) damage in semen as surrogate marker for nucleoside analogue toxicity Conference reports - Side effects - World AIDS 13 Durban 2000 - 16 August 2000
- Antiretrovirals and fertility – implications for couples looking to conceive Conference reports - World AIDS 13 Durban 2000 - 16 August 2000
- Incidence of adverse events at 4 weeks correlates with adherence and virologic failure at 4 months Conference reports - Side effects - World AIDS 13 Durban 2000 - 16 August 2000
- Prednisone and nevirapine rash Conference reports - Side effects - World AIDS 13 Durban 2000 - 16 August 2000
- The prevalence of hypogonadism in HIV-positive patients receiving HAART Conference reports - Other news - World AIDS 13 Durban 2000 - 16 August 2000
- Human papilloma virus and HIV Conference reports - Opportunistic infections and complications - World AIDS 13 Durban 2000 - 16 August 2000
- $1bn drug deal creates debt for "tomorrow's AIDS orphans" Other news - Treatment access - 16 August 2000
- Evaluating structured treatment interruptions: rationale, experience, potential risks and benefits On the web - 16 August 2000